Kidney Research UK: Transforming Treatments for People Living with Kidney Disease
Kidney Research UK in collaboration with Dr James Burton highlight the unmet needs in research, the urgency and importance of transforming treatments for people living with kidney disease.
Find out more at: https://www.kidneyresearchuk.
Support: Published in collaboration with Kidney Research UK.
Share this Video
Related Videos In Chronic Kidney Disease
Jennifer Green, EASD 2022: Combination effect of finerenone and empagliflozin in participants with chronic kidney disease and type 2 diabetes: The CONFIDENCE Study
Finerenone (a selective nonsteroidal mineralocorticoid receptor antagonist) and the SGLT2 inhibitor empagliflozin may reduce both kidney and cardiovascular risks in people with chronic kidney disease and type 2 diabetes. It is unknown whether dual therapy with finerenone and empagliflozin is superior to either agent alone. In this touchENDOCRINOLOGY interview, Prof. Jennifer Green (Duke University School […]
Jennifer Green, EASD 2022: Unmet needs in reducing the risk of chronic kidney disease in people with type 2 diabetes
There is a high unmet need for new treatments to preserve kidney function and delay kidney disease progression in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). In this touchENDOCRINOLOGY interview, Prof. Jennifer Green (Duke University School of Medicine, Durham, NC, USA) discusses the unmet needs in reducing the risk of CKD […]
Peter Rossing, EASD 2022: The effect of semaglutide on risk of MACE by baseline kidney function: SUSTAIN 6 and PIONEER 6 post hoc analysis
SUSTAIN 6 and PIONEER 6 investigated the effects of semaglutide versus placebo on major adverse cardiovascular events (MACE). The current post hoc analysis investigated the association between baseline kidney function and risk of MACE, and the effect of semaglutide on risk of MACE by baseline kidney function. In this touchENDOCRINOLOGY interview, Prof. Peter Rossing (University […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!